Dysregulation of Tau is an important characteristic in a variety of neurodegenerative diseases, such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD) and also mediated the toxicity of amyloid-β (Aβ). This evidence concerns the gene MAPT and Alzheimer disease.